Company Updates
There are 32 results matching your search criteria
Clear all filters
Breath Biopsy
Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy
Breath Biopsy
Owlstone Medical Launches Breath Testing for Digestive Health in Collaboration with Functional Gut Diagnostics and Functional Gut Clinic
Company Updates
Owlstone Medical Expands U.S. Operations and Establishes Permanent U.S. Office
Company Updates
Owlstone Medical Appoints Neil Tween as Chief Financial Officer
Company Updates
Owlstone Medical named as one of FierceMedTech’s “Fierce 15” companies of 2019
Breath Biopsy
Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-Invasive Breath Biopsy
Breath Biopsy
Owlstone Medical Partners with Shanghai Renji Hospital to Pioneer Breath Biopsy Lung Cancer Trial in China
Company Updates
Owlstone Medical Named in Top 10 Disruptors to Watch by Sunday Times
Company Updates
Owlstone Medical Appoints Dr Richard A Yost to Scientific Advisory Board
Company Updates
Owlstone Medical Completes $50 Million USD (c.£38 Million GBP) Financing Round
Company Updates
Owlstone Medical Appoints Dr Andy Richards CBE to Board of Directors
